← Back to Search

Behavioural Intervention

OXD01 digital therapy for Opioid Use Disorder

N/A
Waitlist Available
Research Sponsored by Orexo AB
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from week 6 to week 25
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new digital therapy tool called OXD01 along with standard medication to help patients with opioid addiction. The goal is to see if this combination can better reduce opioid use compared to medication alone. The digital tool provides therapy sessions through devices to support mental health.

Eligible Conditions
  • Opioid Use Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from week 6 to week 25
This trial's timeline: 3 weeks for screening, Varies for treatment, and from week 6 to week 25 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
change of Opioid use

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: SL BUP/NAL SOC background therapyExperimental Treatment1 Intervention
standard of care. Subjects in both groups will receive the assigned treatment for 24 weeks. Subjects in both groups may also be encouraged to participate in behavioral health therapies in accordance with the Investigator's standard of practice.
Group II: SL BUP/NAL + OXD01Experimental Treatment2 Interventions
standard of care + OXD01 (digital therapy). Subjects in both groups will receive the assigned treatment for 24 weeks. Subjects in both groups may also be encouraged to participate in behavioral health therapies in accordance with the Investigator's standard of practice.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
OXD01 digital therapy
2021
N/A
~440

Find a Location

Who is running the clinical trial?

Orexo ABLead Sponsor
6 Previous Clinical Trials
1,793 Total Patients Enrolled
~101 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top